Without any significant news, there will be no interest and the stock will, once again, dive on light volume. The longer the delay in news based on the anticipated date of today given by the company will only hurt the stock price. Isnub, as you call it, is quite a funny board. They are already planning a party when nothing has yet come to fruition. For their sake, I hope news does come to justify their way too early enthusiasm. This company is far from a sure bet and many in this stock seem not to understand how risky biotechs are. No one knows if HemaXellerate will work in humans. The rodent model is a highly unreliable predictor of how a drug/procedure will work in humans.